The global internal neuromodulation market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic pain and neurological disorders, rising geriatric population, and technological advancements in the field of neuromodulation.
The spinal cord stimulator segment accounted for the largest share in the global internal neuromodulation market in 2018. The deep brain stimulator segment is expected to grow at a CAGR of 6% during the forecast period, from 2021 to 2030. The chronic pain application segment accounted for the largest share in this market in 2018 and it is expected to continue its dominance throughout the forecast period due to increasing prevalence of chronic pain globally.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic pain and neurological disorders is driving the growth of the Internal Neuromodulation market.
- Increasing adoption of minimally invasive procedures for treatment of chronic pain and neurological disorders is also driving the growth of the Internal Neuromodulation market.
- Increasing number of clinical trials for new drugs in various therapeutic areas such as neurology, oncology, and cardiology are also driving the growth of this market.
- Growing geriatric population base globally will drive demand for neuromodulators.
Industry Growth Insights published a new data on “Internal Neuromodulation Market”. The research report is titled “Internal Neuromodulation Market research by Types (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator), By Applications (Parkinsons Disease, Chronic Pain, Others), By Players/Companies Medtronic PLC, St. Jude Medical, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Internal Neuromodulation Market Research Report
By Type
Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator
By Application
Parkinsons Disease, Chronic Pain, Others
By Companies
Medtronic PLC, St. Jude Medical, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Internal Neuromodulation Market Report Segments:
The global Internal Neuromodulation market is segmented on the basis of:
Types
Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinsons Disease, Chronic Pain, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic PLC
- St. Jude Medical
- Boston Scientific Corp.
- Cerbomed GMBH
- Cyberonics
- Biocontrol Medical
- Depuy Synthes Companies
- Enteromedics
- Synapse Biomedical
- Uroplasty
- Greatbatch
Highlights of The Internal Neuromodulation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spinal Cord Stimulator
- Deep Brain Stimulator
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Gastric Neuro Stimulator
- By Application:
- Parkinsons Disease
- Chronic Pain
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Internal Neuromodulation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Internal neuromodulation is a term used to describe the use of electrical stimulation devices to improve nerve function. This can be done through the use of implanted electrodes, or by using externally applied stimulators.
Some of the key players operating in the internal neuromodulation market are Medtronic PLC, St. Jude Medical, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch.
The internal neuromodulation market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Internal Neuromodulation Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Internal Neuromodulation Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Internal Neuromodulation Market - Supply Chain
4.5. Global Internal Neuromodulation Market Forecast
4.5.1. Internal Neuromodulation Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Internal Neuromodulation Market Size (000 Units) and Y-o-Y Growth
4.5.3. Internal Neuromodulation Market Absolute $ Opportunity
5. Global Internal Neuromodulation Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Internal Neuromodulation Market Size and Volume Forecast by Type
5.3.1. Spinal Cord Stimulator
5.3.2. Deep Brain Stimulator
5.3.3. Sacral Nerve Stimulator
5.3.4. Vagus Nerve Stimulator
5.3.5. Gastric Neuro Stimulator
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Internal Neuromodulation Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Internal Neuromodulation Market Size and Volume Forecast by Application
6.3.1. Parkinsons Disease
6.3.2. Chronic Pain
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Internal Neuromodulation Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Internal Neuromodulation Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Internal Neuromodulation Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Internal Neuromodulation Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Internal Neuromodulation Demand Share Forecast, 2019-2026
9. North America Internal Neuromodulation Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Internal Neuromodulation Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Internal Neuromodulation Market Size and Volume Forecast by Application
9.4.1. Parkinsons Disease
9.4.2. Chronic Pain
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Internal Neuromodulation Market Size and Volume Forecast by Type
9.7.1. Spinal Cord Stimulator
9.7.2. Deep Brain Stimulator
9.7.3. Sacral Nerve Stimulator
9.7.4. Vagus Nerve Stimulator
9.7.5. Gastric Neuro Stimulator
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Internal Neuromodulation Demand Share Forecast, 2019-2026
10. Latin America Internal Neuromodulation Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Internal Neuromodulation Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Internal Neuromodulation Market Size and Volume Forecast by Application
10.4.1. Parkinsons Disease
10.4.2. Chronic Pain
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Internal Neuromodulation Market Size and Volume Forecast by Type
10.7.1. Spinal Cord Stimulator
10.7.2. Deep Brain Stimulator
10.7.3. Sacral Nerve Stimulator
10.7.4. Vagus Nerve Stimulator
10.7.5. Gastric Neuro Stimulator
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Internal Neuromodulation Demand Share Forecast, 2019-2026
11. Europe Internal Neuromodulation Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Internal Neuromodulation Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Internal Neuromodulation Market Size and Volume Forecast by Application
11.4.1. Parkinsons Disease
11.4.2. Chronic Pain
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Internal Neuromodulation Market Size and Volume Forecast by Type
11.7.1. Spinal Cord Stimulator
11.7.2. Deep Brain Stimulator
11.7.3. Sacral Nerve Stimulator
11.7.4. Vagus Nerve Stimulator
11.7.5. Gastric Neuro Stimulator
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Internal Neuromodulation Demand Share, 2019-2026
12. Asia Pacific Internal Neuromodulation Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Internal Neuromodulation Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Internal Neuromodulation Market Size and Volume Forecast by Application
12.4.1. Parkinsons Disease
12.4.2. Chronic Pain
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Internal Neuromodulation Market Size and Volume Forecast by Type
12.7.1. Spinal Cord Stimulator
12.7.2. Deep Brain Stimulator
12.7.3. Sacral Nerve Stimulator
12.7.4. Vagus Nerve Stimulator
12.7.5. Gastric Neuro Stimulator
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Internal Neuromodulation Demand Share, 2019-2026
13. Middle East & Africa Internal Neuromodulation Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Internal Neuromodulation Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Internal Neuromodulation Market Size and Volume Forecast by Application
13.4.1. Parkinsons Disease
13.4.2. Chronic Pain
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Internal Neuromodulation Market Size and Volume Forecast by Type
13.7.1. Spinal Cord Stimulator
13.7.2. Deep Brain Stimulator
13.7.3. Sacral Nerve Stimulator
13.7.4. Vagus Nerve Stimulator
13.7.5. Gastric Neuro Stimulator
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Internal Neuromodulation Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Internal Neuromodulation Market: Market Share Analysis
14.2. Internal Neuromodulation Distributors and Customers
14.3. Internal Neuromodulation Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic PLC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. St. Jude Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific Corp.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cerbomed GMBH
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cyberonics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biocontrol Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Depuy Synthes Companies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Enteromedics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Synapse Biomedical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Uroplasty
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Greatbatch
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
